BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3334667)

  • 1. Sensitivity to cefuroxime and ceftazidime of hospital strains isolated in Poland.
    Kedzia W; Zawieja M; Mirska I
    Chemioterapia; 1987 Jun; 6(2 Suppl):79-80. PubMed ID: 3334667
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].
    Giedrys-Kalemba S; Bilska I
    Med Dosw Mikrobiol; 1993; 45(2):173-6. PubMed ID: 8309292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefuroxim resistance of pathogenic strains isolated in a pediatric environment].
    Pinto L; Di Lena C; Marchi K; Jolascon A; Vitale R
    Pediatria (Napoli); 1979 Sep; 87(3):421-6. PubMed ID: 550115
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity to augmentin and cephalosporines of some bacterial strains isolated from hospitalized patients.
    Debeleac L; Iancu A; Tudorache D; Iancu G
    Rom J Intern Med; 1995; 33(3-4):227-35. PubMed ID: 8646195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-microbiological evaluation of ketotsef].
    Karpenko VS; Grin'ko AD; Rudenko AV; Chaĭkovskaia VL; Nikonova NA
    Vrach Delo; 1983 Mar; (3):93-5. PubMed ID: 6858118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of the antibiotic activity of cefuroxime].
    Bil'ko IP; Mil'chenko KP; Ginzburg TS; Sokalo SV
    Antibiotiki; 1982 Aug; 27(8):595-8. PubMed ID: 6751214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbiological tests of 2 recent cephalosporins: cefadroxil and cefuroxime].
    Delia S; Mauro A; Zaccone R
    Ann Sclavo; 1980; 22(6):957-63. PubMed ID: 7294912
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications.
    Hui M; Lam PT; Cheung SW; Pang CP; Chan CY; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):164-70. PubMed ID: 20796261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 17. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates to cephalosporins.
    Rattan A
    Indian Pediatr; 1989 Sep; 26(9):965-6. PubMed ID: 2699321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.